Rangers Roundup: Brendan Lemieux situation, Jordan Greenway trade, and more

While we wait to see what happens between the Rangers and Ryan Strome, there’s another RFA as well. Brendan Lemieux is likely waiting for that domino to fall before inking a new deal.

Brendan Lemieux contract situation

Larry Brooks recently wrote about the topics of both Lemieux and Strome. With regards to the rugged winger he wrote:

I would envision Lemieux receiving somewhere in the neighborhood of $1.75M to $2M on a two-year arbitration award, off a career in which he has 36 points (19-17) in 131 contests. Jordan Greenway, Minnesota’s 23-year-old winger who played for David Quinn at Boston University and about whom the Blueshirts have inquired more than once, recently signed a two-year deal with the Wild at $2.1M per season with a career total of 53 points (20-33) in 154 games.


I’ve written in the past about Lemieux and expect him to sign a new deal close to that $2 million mark. As far as it goes with Strome, last week I was told the two sides were close and the haggle is over term.

rangers trade rumors
Brendan Lemieux (Getty Images)

Rangers looking at Jordan Greenway

What should not be overlooked is Brooks mentioning the Rangers trying to acquire 6’6″ LW Jordan Greenway. The 23 year-old native New Yorker can play. Last season he scored 28 points in 67 games, and the year prior he notched 24 in 81.

The Wild use Greenway mostly as a bottom six winger. The former BU forward under David Quinn would be utilized the same way. Of course, that sounds like a Lemieux replacement so this is one to keep an eye on.

NHL news and notes

Restricted free agents continue to sign on the dotted line as both Devon Toews and Haydn Fleury agreed to new deals. Also, Tyler Bertuzzi was the first RFA to get to an actual hearing and received his award of $3.5 million.

Read all about it here!

Anthony Scultore has been covering the New York Rangers and the NHL since 2014. His work also appears at... More about Anthony Scultore

Mentioned in this article:

More About: